Bioink Market is Set to Surge at 18.8% CAGR, to Reach US$ 1.03 Billion by 2034: Fact.MR Report

The size of the global bioink market is estimated at US$ 185.6 million in 2024, according to a new study released by Fact.MR. Global demand for bioinks is expected to grow at a prolific CAGR of 18.8% and reach a market value of US$ 1.03 billion through the end of 2034.

Continuous development in 3D printing technology is expected to drive growth in the sales of compatible bioinks in the future. Technology improvements facilitate the creation of more intricate, functional, and accurate organ and tissue printing, which requires manufacturing of specialized bioinks capable of replicating natural tissues.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9475

What is Driving Fast Global Bioink Market Growth?

"Rising Cases of Organ Failure Necessitating Production of 3D Printed Organs

Increased cases of organ failure due to various causes, such as accidents, burns, old age, and poor lifestyle, are expected to lead to growing demand for bioinks because of the increased demand for 3D-printed organs. The process of 3D printing is expected to assist in addressing the challenges of organ shortages worldwide. There is no real drug therapy available to reverse organ failure.

The Organ Procurement and Transplantation Network issued a report in 2021. According to the statistics presented via the report, around 180,000 patients suffer from renal failure every year and 6,000 renal transplants are conducted.

Country-wise Insights

North America is also predicted to have 56.9% market share in the world by 2034, according to the report by Fact.MR, a market research and competitive intelligence company. Growing adoption of 3D bioprinters and greater investments by firms to offer tissue-specific bioinks are expected to drive revenue streams in the future.

China is projected to hold a 46.6% share of the East Asian market in 2034. The Chinese government is actively striving to be self-reliant in the biopharma business. Enhancement of the Chinese biopharmaceutical business is one of the priority areas for the government in China. Apart from that, significant investments made by the government in biotech R&D exercises are projected to broaden opportunities for players.

Category-wise Insights

Worldwide demand for collagen-based bioinks is anticipated to grow immensely due to their improved compatibility and contribution towards the construction of fibrous networks for the human body. These trends in the bioink market are anticipated to create financially rewarding opportunities for players in the future.

The collagen segment is anticipated to capture 19% of the world market by 2034. Collagen is employed as one of the major structural elements of tendon, bone, skin, and other connective tissues. The facile compatibility of collagen coupled with its capacity to create a fibrous network in the human body is expected to drive its uptake.

Browse Full Report: https://www.factmr.com/report/bioink-market

Competitive Landscape

Leading producers of bioinks are supplying technologically superior products. Besides, mergers & acquisitions to expand offerings are undertaken by them. Moreover, quality control of products, supply chain management, and R&D are expected to assist these players in achieving a competitive advantage.

For example :

CollPlant introduced Collink.3DTM to use in the 3D bioprinting of human organs, scaffolds, and tissues during November 2021.
BICO bought Advanced BioMatris in August 2021. The latter is specialized in 3D research applications and is America-based with a robust portfolio of collagen bioinks, chemically modified proteins, and other cell assays.

Some major players in the bioink market include Merck KGaA, CELLINK, BICO, CollPlant Biotechnologies Ltd., Humabiologics, Allevi, Inc., Black Drop Biodrucker Gmb, Foldink, UPM Biomedicals, Axolotl Biosciences, Manchester BIOGEL, TheWell Bioscience Inc., and 3DPL.

Segmentation of Bioink Market Research

By Material:
Agarose
Alginate
Chitosan
Collagen
Fibrinogen
Gelatin
Hyaluronic Acid
Graphene
Hydroxyapatite
Cell- & Tissue-derived ECM
Poly (Ethylene Glycol) Diacrylate (PEGDA)
By Source:
Natural
Synthetic
By Printing Modality:
Extrusion-based Bioprinting
Inkjet-based Bioprinting
Laser-based Bioprinting
By Application:
Tissue Engineering & Regenerative Medicines
Tissue Transplantation
Pharmaceuticals & High-throughput Screening
By Organ:
Human Ears
Kidneys
Liver
Heart
Skin
Cartilages
Bones
Stem Cells
Blood Vessels
Cancer Research
Lungs
Muscles
By End User:
Medical Device Manufacturers
Pharmaceutical Companies
Research & Academic Institutions
Contract Research Organizations
By Region:
North America
Europe
East Asia
Latin America
Middle East & Africa
South Asia & Oceania

Check out More Related Studies Published by Fact.MR:

Postpartum Hemorrhage (PPH) Treatment Devices Market
https://www.factmr.com/report/postpartum-hemorrhage-pph-treatment-devices-market

Breast Imaging Technologies Market
https://www.factmr.com/report/breast-imaging-technologies-market

Venipuncture Procedure Market
https://www.factmr.com/report/venipuncture-procedure-market

Dental Mirrors Market
https://www.factmr.com/report/dental-mirrors-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.